Past Project
Creactive
Fall 2024 / 2025
About
The work, in plain language.
Roughly 10 percent of the global population lives with chronic kidney disease, and when the kidneys fail, waste products accumulate in the bloodstream. Creatinine, a byproduct of muscle metabolism, is one of the standard biomarkers used to estimate glomerular filtration rate, but tracking it currently requires regular trips to a clinic.
Creactive explored whether biosensors could shift creatinine monitoring from one-time clinical tests to continuous measurement, potentially sparing kidney-disease patients from repeated hospital visits.
The legacy project page also connected this work with the 2025 SensUs competition theme, which focused on continuous creatinine biosensors.
Project archive
Images from the original project page.
These images are preserved in the same order as the legacy McGill BioDesign page.
View the original project pageCreactive project archive, image 1 of 2.
1 / 2
Team
Led by.
Every project starts with a lead who carries it from idea to build. Want to lead the next one?
Related